Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1973 Dec;46(5):693–701.

Immunological studies on malignant melanomas of man.

M M Romsdahl, I S Cox
PMCID: PMC2592017  PMID: 4205125

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  3. Fass L., Herberman R. B., Ziegler J. L., Kiryabwire J. W. Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet. 1970 Jan 17;1(7638):116–118. doi: 10.1016/s0140-6736(70)90467-8. [DOI] [PubMed] [Google Scholar]
  4. Fossati G., Colnaghi M. I., Porta G. D., Cascinelli N., Veronesi U. Cellular and humoral immunity against human malignant melanoma. Int J Cancer. 1971 Sep 15;8(2):344–350. doi: 10.1002/ijc.2910080221. [DOI] [PubMed] [Google Scholar]
  5. Giovanella B. C., Yim S. O., Stehlin J. S., Williams L. J., Jr Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells. J Natl Cancer Inst. 1972 May;48(5):1531–1533. [PubMed] [Google Scholar]
  6. Hellström I., Hellström K. E., Pierce G. E., Yang J. P. Cellular and humoral immunity to different types of human neoplasms. Nature. 1968 Dec 28;220(5174):1352–1354. doi: 10.1038/2201352a0. [DOI] [PubMed] [Google Scholar]
  7. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  8. Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Fairley G. H., Bodenham D. C., Alexander P. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J. 1969 Sep 6;3(5670):547–552. doi: 10.1136/bmj.3.5670.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lewis M. G., Phillips T. M. The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer. 1972 Jul 15;10(1):105–111. doi: 10.1002/ijc.2910100114. [DOI] [PubMed] [Google Scholar]
  10. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  11. Oettgen H. F., Aoki T., Old L. J., Boyse E. A., de Harven E., Mills G. M. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst. 1968 Oct;41(4):827–843. [PubMed] [Google Scholar]
  12. Romsdahl M. M., Cox I. S. Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch Surg. 1970 Apr;100(4):491–497. doi: 10.1001/archsurg.1970.01340220167028. [DOI] [PubMed] [Google Scholar]
  13. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  14. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  15. Wood W. C., Morton D. L. Microcytotoxicity test: detection in sarcoma patients of antibody cytotoxic to human sarcoma cells. Science. 1970 Dec 18;170(3964):1318–1320. doi: 10.1126/science.170.3964.1318. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES